Intervention Description Section
CONSORT 2025 requires enough detail about each intervention and comparator to understand what participants received and, where feasible, to support replication. The level of detail depends on the intervention and reporting standard. Do not force drug-style fields onto behavioral, procedural, policy, or other non-drug interventions.
An Intervention Description section explains what each study group received, including the key components, delivery, timing, duration, and comparator details relevant to replication.
Key details
Important caveats
Scope Boundary
The level of detail depends on the intervention and reporting standard. Do not force drug-style fields onto behavioral, procedural, policy, or other non-drug interventions.
Further guidance
Content
Include material details such as components, mode of delivery, dose or intensity when applicable, timing, duration, tailoring, and relevant co-interventions without repeating the entire study design.
Purpose
Describe each intervention and comparator clearly enough that readers can understand what was delivered and how the study groups differed.
Sources and evidence
Sources are shown with the role they play in this guide. Historical or style-sensitive claims are kept within the evidence boundary described above.
- CONSORT 2025 statement: updated guideline for reporting randomised trials (opens in a new tab)BMJ / CONSORT Group · Primary 2025 CONSORT reporting guideline for randomized trials, including participant flow and trial-registration information.